Patients diagnosed with T2DM have an increased risk of both cardiovascular and neurological diseases
Melatonin improves stroke through MDM2-mediated ubiquitination of ACSL4
Figure 3 6 Conclusion In summary, tirzepatide, a dual agonist of the GLP-1 and GIP receptors, shows promising potential for the management of obesity-related OSAS by promoting weight loss, improving metabolic function, and modulating inflammatory pathways
Other notable semaglutide drugs include Rybelsus and Wegovy
For example, a randomized trial published in 2021 shows that patients older than 60 years of age who had a diabetes duration of 10+ years were at higher risk of DR progression specifically when using semaglutide
Greene ponders, is there a potential risk for something similar to what you see with synthetic growth hormone